What Analysts Are Recommending for GILD and ABBV in February
GILD or ABBV: Which Is a Better Biotech Pick This Month?Share price movementsOn February 15, Gilead Sciences (GILD) closed at $67.59, 1.84% higher than its previous closing price, 12.05% higher than its 52-week low of $60.32, and 18.29% lower than